NIH Grants Nemours $5.32 Million for Sickle Cell
A five-year federal grant extends sickle cell disease research at Nemours Children's Health in Delaware.
Updated on Nov. 12, 2026 in Children’s Health

Live Poll
Should the federal government spend more on research for sickle cell disease?
The National Institutes of Health awarded Nemours Children's Health a five-year, $5.32 million grant for sickle cell disease research. The award marks the start of phase 3 of the institution's ongoing sickle cell work.
Why it matters
Sickle cell disease is an inherited blood disorder affecting about 100,000 people in the United States, more than 90% of whom are non-Hispanic Black or African American. The grant is expected to build Delaware's capacity to deliver research-based care for patients living with the disease.
The five-year NIH grant totals $5.32 million, following $10.2 million in 2014 and $10.5 million in 2021 awarded to Nemours for sickle cell research. The grant supports up to eight one-year pilot projects, and the source does not report results from them.
The players
Nemours Children's Health
A pediatric health system operating Nemours Children's Hospital in Delaware, which received the grant and houses the sickle cell research center.
National Institutes of Health
The federal agency that funds biomedical research in the United States and awarded the five-year grant to Nemours.
The details
The grant builds on earlier Nemours awards that helped launch the Delaware Comprehensive Sickle Cell Research Center. It sustains support for Nemours researchers and funds innovative projects, including up to eight one-year pilot projects.
Timeline
2014: Nemours received a $10.2 million sickle cell grant.
2021: Nemours received a $10.5 million sickle cell grant.
November 11, 2026: The NIH awarded the five-year, $5.32 million grant.
Program Continuity
The grant extends the Delaware Comprehensive Sickle Cell Research Center, which Nemours helped launch with its 2014 and 2021 awards, into phase 3 of its research. The funding continues a pattern of roughly five-year federal support that has sustained the center's work over more than a decade.
Families of children with sickle cell disease in Delaware may gain access to research-based care as the center's pilot projects develop. The grant does not change current treatment options or insurance coverage for patients.
The takeaway
Sustained federal research funding can extend a single institution's work across multiple years and phases. For families affected by sickle cell disease, ongoing research may eventually narrow the life-expectancy gap the disease creates.
Further reading
For related coverage, explore more Children's Health stories in Delaware.
Live Poll
Should the federal government spend more on research for sickle cell disease?






